Multi-year Maintenance Agreement for the Flow Cytometry Cores BD FACSAria II Special Cell Sorter System
INTRODUCTION:
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), on intends to negotiate and award a purchase order on a sole source noncompetitive basis to Becton, Dickinson and Company, 2350 Qume Dr., San Jose, CA, 95131-1812 to provide maintenance to the Flow Cytometry Core's BD FACSAria II Special Cell Sorter System.
PROCUREMENT:
The contractor shall provide the following:
Maintenance Services for the following equipment:
1. FACSAria II Special, Serial Number: P650033024
2. Laser Red Coherent Cube 637-150
3. Svc Cont SAPPHIRE 200 MW Blue laser
4. Svc Cont Laser Violet 405-100
5. Svc Lightwave XCYTE 60mw UV laser
6. Svc Cont SORP Coherent Sapphire 532-200
These maintenance services include:
• BD FACSAria II Special Order System coverage with one computer workstation (excluding printers) for labor, travel expenses and parts (excluding consumables)
• Two (2) Preventive Maintenance Inspections to be performed during a twelve-month period, including Two (2) Preventative Maintenance Kits
• Software Revisions released during the agreement term
• Unlimited service visits, Monday-Friday, excluding government holidays
• Unlimited telephone support for instruments, reagents and applications
• 48 hour emergency on-site service response time (Monday through Friday, excluding government holidays)
BACKGROUND:
The mission of the NHLBI Division of Intramural Research (DIR) is to perform robust scientific and clinical research leading to a better understanding of biology and clinical pathology. To attain this goal, we have built a strong basic science foundation and coupled it closely with innovative technology development and outstanding clinical research both at the NIH Clinical Center and in partnership with local hospitals.
The purview of our research is broad, encompassing investigations into the basic principles of molecular, cellular, and organ-level biology and their relationship to disease. Some current areas of fundamental interest include single molecule structure; protein assembly; molecular and cell biology; cell signaling and motility; membrane trafficking; physiology; systems biology; engineering and technology development. Insights into disease mechanisms derived from basic studies form the basis for translational research into new diagnostic and therapeutic approaches.
DIR investigators also conduct concept-based clinical studies in the areas of interventional and surgical cardiology; pulmonary medicine; sickle cell anemia; bone marrow transplant; and hematologic disorders.
The mission of the Flow Cytometry Core Facility at the National Heart, Lung and Blood Institute is to provide state of the art cell analysis using flow cytometry. It is necessary for the ongoing research in cardiology, hematology, and lung diseases.
For the optimal results in identifying cell populations determined by using lasers, and the highly complex and sensitive electronics of the BD FACSAria for cell sorting, a maintenance contract must be in place to have specially trained engineers for service and routine timely maintenance to ensure the least amount of downtime of the cell sorter. A maintenance contract must provide phone service and prompt service calls by highly qualified engineers, to maximize the uptime and productivity for uninterrupted service to the Institute
PURPOSE AND OBJECTIVE:
This acquisition is for the purpose of procuring a multi-year maintenance agreement for the Flow Cytometry Core's BD FACSAria II Special Cell Sorter System.
ANTICIPATED PERIOD OF PERFORMANCE:
Base: December 18, 2014 through December 17, 2015
Option Period 1: December 18, 2015 through December 17, 2016
Option Period 2: December 18, 2016 through December 17, 2017
Option Period 3: December 18, 2017 through December 17, 2018
Option Period 4: December 18, 2018 through December 17, 2019
JUSTIFICATION:
The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research.
BD Biosciences is the sole manufacturer of the BD FACSAria II and does not certify third party organizations to perform service on equipment. BD Biosciences is the only manufacturer that can supply spare or replacement parts which are unique to BD FACSAria II Special Cell Sorter System.
REGULATORY AUTHORITY:
This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1(b) Soliciting from a single source, only one responsible source and no other supplies or services will satisfy agency requirements.
ADDITIONAL INFORMATION:
Industry Classification (NAICS) Code is 811219, Other Electronic and Precision Equipment Repair and Maintenance and the Small Business Size Standard is $20.5 Million. This acquisition is conducted under the procedures as prescribed in FAR subpart 12-Acquisition of Commercial Items and FAR subpart 13-Simplified Acquisition Procedures FAR subpart 15-Contracting by Negotiation at an amount exceeding the simplified acquisition threshold ($150,000).
The solicitation document, the incorporated provisions and clauses are those in the Federal Acquisition Circular 2005-77, effective October 14, 2014.
The determination by the Government to award a purchase order on a sole source noncompetitive basis to provide a multi-year maintenance agreement for the BD FACSAria II Special Cell Sorter System, 2350 Qume Dr., San Jose, CA, 95131-1812, is based upon the market research conducted in accordance with one or more of the techniques specified in FAR Part 10-Market Research, Subpart 10.002(b)(2).
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by November 04, 2014 at 12:00 p.m. EST. Responses must reference synopsis number HHS-NIH-NHLBI-CSB-HI-2015-020-CDB, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6121A, Bethesda, Maryland 20892-7902, Attention: Chris Bocus. Response may be submitted electronically to chris.bocus@ nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
Chris Bocus, Phone 3014027888, Email chris.bocus@nih.gov
